| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |